These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16933591)

  • 41. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR; Elhaj O; Gajwani P; Gao K
    J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
    Reed C; Novick D; Gonzalez-Pinto A; Bertsch J; Haro JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):715-21. PubMed ID: 19345251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
    Rosaria Muscatello M; Pacetti M; Cacciola M; La Torre D; Zoccali R; D'Arrigo C; Migliardi G; Spina E
    Epilepsia; 2005 May; 46(5):771-4. PubMed ID: 15857446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder.
    Popovic D; Reinares M; Goikolea JM; Bonnin CM; Gonzalez-Pinto A; Vieta E
    Eur Neuropsychopharmacol; 2012 May; 22(5):339-46. PubMed ID: 22000157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Olanzapine in the treatment of bipolar disorder].
    Krüger S
    Psychiatr Prax; 2006 Mar; 33 Suppl 1():S18-26. PubMed ID: 16511727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
    McIntyre RS
    Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and tolerability of anticonvulsant medication in bipolar disorder.
    Pichler EM; Hattwich G; Grunze H; Muehlbacher M
    Expert Opin Drug Saf; 2015; 14(11):1703-24. PubMed ID: 26359219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.
    Fountoulakis KN; Grunze H; Vieta E; Young A; Yatham L; Blier P; Kasper S; Moeller HJ
    Int J Neuropsychopharmacol; 2017 Feb; 20(2):180-195. PubMed ID: 27941079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review of recent guidelines for pharmacological treatments of bipolar disorders in adults.
    Hammett S; Youssef NA
    Ann Clin Psychiatry; 2017 Nov; 29(4):266-282. PubMed ID: 29069112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
    Centorrino F; Albert MJ; Berry JM; Kelleher JP; Fellman V; Line G; Koukopoulos AE; Kidwell JE; Fogarty KV; Baldessarini RJ
    Bipolar Disord; 2003 Oct; 5(5):370-4. PubMed ID: 14525559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical use of carbamazepine for bipolar disorders.
    Wang PW; Ketter TA
    Expert Opin Pharmacother; 2005 Dec; 6(16):2887-902. PubMed ID: 16318439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy.
    Ajayi OO; Holroyd S
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29197846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression.
    Reinares M; Rosa AR; Franco C; Goikolea JM; Fountoulakis K; Siamouli M; Gonda X; Frangou S; Vieta E
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):485-96. PubMed ID: 22575611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research.
    Fountoulakis KN; Vieta E; Young A; Yatham L; Grunze H; Blier P; Moeller HJ; Kasper S
    Int J Neuropsychopharmacol; 2017 Feb; 20(2):196-205. PubMed ID: 27677983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of pharmacotherapy for bipolar I disorder.
    Morsel AM; Morrens M; Sabbe B
    Expert Opin Pharmacother; 2018 Feb; 19(3):203-222. PubMed ID: 29361880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder?
    Chia MF; Cotton S; Filia K; Phelan M; Conus P; Jauhar S; Marwaha S; McGorry PD; Davey C; Berk M; Ratheesh A
    J Affect Disord; 2019 Oct; 257():669-677. PubMed ID: 31377603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flying almost blind.
    Leibenluft E
    Am J Psychiatry; 2006 Jul; 163(7):1129-31. PubMed ID: 16816212
    [No Abstract]   [Full Text] [Related]  

  • 60. What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines.
    Gomes FA; Cerqueira RO; Lee Y; Mansur RB; Kapczinski F; McIntyre RS; Yatham LN; Berk M; Milev R; Brietzke E
    J Affect Disord; 2022 Feb; 298(Pt A):565-576. PubMed ID: 34758372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.